AGM Statement

Victrex PLC
05 February 2008


                            Tuesday 5 February 2008   
                                     
                                                                              
                                  Victrex plc                                        
                                        
                      AGM and Interim Management Statement


At the Annual General Meeting of Victrex plc to be held today, Chairman Peter 
Warry will make the following statement which comprises Victrex's first Interim 
Management Statement covering the period from 1 October 2007 to date:


'Trading since our December preliminary announcement has continued in line with
expectations. We saw an encouraging start to the calendar year with January
sales volume growing above the levels achieved in October and November. This
followed an expected softening in December reflecting normal seasonal trading
patterns. Accordingly, while it is too early to predict the outcome for the year
as a whole, we remain confident in the underlying growth potential for the
business.


There have been no significant changes in the financial position of the Company
since 30 September 2007.'


The Company's half yearly trading update for the six months to 31 March 2007
will be issued on Friday 4 April 2008.


                                    - Ends -


For further information please contact:

Victrex plc                               0207 357 9477 (5 February 2008)
Michael Peacock, Finance Director         01253 897700 (thereafter)

Hogarth Partnership Limited               0207 357 9477
Barnaby Fry / Nick Denton


Victrex plc is an innovative, world leader in high performance materials through
the manufacture of VICTREX(R) PEEK(TM) polymer, a high performance, easy to 
process thermoplastic.


VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysis
and temperature resistance, as well as excellent dimensional, mechanical and
chemical stability combined with inherent purity and low flammability.


End users specify VICTREX PEEK to reduce systems costs, improve part
performance, exploit greater design freedom and create a differentiated
application. VICTREX PEEK is used across a broad range of applications in
diverse markets including transport, industrial, electronics and medical.
Invibio(R), Victrex's biomaterial business, provides specialised solutions for
medical device manufacturers.


The Group's headquarters are in the UK where its manufacturing facilities are
based. This is complemented by a global network of sales, distribution and
technical centres that serve more than 30 countries worldwide.



                      This information is provided by RNS
            The company news service from the London Stock Exchange
    
AGMILFESFVISIIT